Cargando…

High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2

Anti-virulence therapies are under active investigation as antibiotic alternatives; however, their identification from large-scale chemical libraries poses a unique challenge. The dispensability of virulence factors for growth in vitro precludes conventional, optical density-based screening methods....

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Caressa N., Coombes, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580248/
https://www.ncbi.nlm.nih.gov/pubmed/33111100
http://dx.doi.org/10.1016/j.xpro.2020.100057
_version_ 1783598750878400512
author Tsai, Caressa N.
Coombes, Brian K.
author_facet Tsai, Caressa N.
Coombes, Brian K.
author_sort Tsai, Caressa N.
collection PubMed
description Anti-virulence therapies are under active investigation as antibiotic alternatives; however, their identification from large-scale chemical libraries poses a unique challenge. The dispensability of virulence factors for growth in vitro precludes conventional, optical density-based screening methods. Here, we provide a protocol for high-throughput screening with a cell-based, promoter reporter platform. We describe the use of this method for the identification of anti-SPI-2 inhibitors specific to Salmonella Typhimurium, which may be modified to investigate other virulence factors. For complete details on the use and execution of this protocol, please refer to Tsai et al. (2020).
format Online
Article
Text
id pubmed-7580248
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75802482020-10-26 High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2 Tsai, Caressa N. Coombes, Brian K. STAR Protoc Protocol Anti-virulence therapies are under active investigation as antibiotic alternatives; however, their identification from large-scale chemical libraries poses a unique challenge. The dispensability of virulence factors for growth in vitro precludes conventional, optical density-based screening methods. Here, we provide a protocol for high-throughput screening with a cell-based, promoter reporter platform. We describe the use of this method for the identification of anti-SPI-2 inhibitors specific to Salmonella Typhimurium, which may be modified to investigate other virulence factors. For complete details on the use and execution of this protocol, please refer to Tsai et al. (2020). Elsevier 2020-06-29 /pmc/articles/PMC7580248/ /pubmed/33111100 http://dx.doi.org/10.1016/j.xpro.2020.100057 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Tsai, Caressa N.
Coombes, Brian K.
High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title_full High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title_fullStr High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title_full_unstemmed High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title_short High-Throughput Chemical Screening for Inhibitors of Salmonella Pathogenicity Island 2
title_sort high-throughput chemical screening for inhibitors of salmonella pathogenicity island 2
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580248/
https://www.ncbi.nlm.nih.gov/pubmed/33111100
http://dx.doi.org/10.1016/j.xpro.2020.100057
work_keys_str_mv AT tsaicaressan highthroughputchemicalscreeningforinhibitorsofsalmonellapathogenicityisland2
AT coombesbriank highthroughputchemicalscreeningforinhibitorsofsalmonellapathogenicityisland2